Operating Margin of RECURSION PHARMACEUTICALS, INC. from 31 Dec 2019 to 31 Dec 2025
- Taxonomy & unit
- ratio: %
- Description
- The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
- Summary
-
RECURSION PHARMACEUTICALS, INC. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2019 to 31 Dec 2025.
- RECURSION PHARMACEUTICALS, INC. Operating Margin for the quarter ending 31 Dec 2025 was -868%, a 6.6% decline year-over-year.
- RECURSION PHARMACEUTICALS, INC. annual Operating Margin for 2025 was -868%, a 6.6% decline from 2024.
- RECURSION PHARMACEUTICALS, INC. annual Operating Margin for 2024 was -814%, a 3.7% decline from 2023.
- RECURSION PHARMACEUTICALS, INC. annual Operating Margin for 2023 was -785%, a 27% decline from 2022.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)
RECURSION PHARMACEUTICALS, INC. Quarterly Operating Margin (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q4 2025 | -868% | -54% | -6.6% | 01 Oct 2025 | 31 Dec 2025 |
| Q3 2025 | -1656% | -1051% | -174% | 01 Jul 2025 | 30 Sep 2025 |
| Q2 2025 | -1006% | -209% | -26% | 01 Apr 2025 | 30 Jun 2025 |
| Q1 2025 | -960% | -146% | -18% | 01 Jan 2025 | 31 Mar 2025 |
| Q4 2024 | -814% | -29% | -3.7% | 01 Oct 2024 | 31 Dec 2024 |
| Q3 2024 | -605% | +54% | +8.2% | 01 Jul 2024 | 30 Sep 2024 |
| Q2 2024 | -797% | -246% | -45% | 01 Apr 2024 | 30 Jun 2024 |
| Q1 2024 | -814% | -258% | -46% | 01 Jan 2024 | 31 Mar 2024 |
| Q4 2023 | -785% | -169% | -27% | 01 Oct 2023 | 31 Dec 2023 |
| Q3 2023 | -659% | +211% | +24% | 01 Jul 2023 | 30 Sep 2023 |
| Q2 2023 | -550% | +742% | +57% | 01 Apr 2023 | 30 Jun 2023 |
| Q1 2023 | -557% | +1052% | +65% | 01 Jan 2023 | 31 Mar 2023 |
| Q4 2022 | -617% | +1179% | +66% | 01 Oct 2022 | 31 Dec 2022 |
| Q3 2022 | -870% | +517% | +37% | 01 Jul 2022 | 30 Sep 2022 |
| Q2 2022 | -1292% | +61% | +4.5% | 01 Apr 2022 | 30 Jun 2022 |
| Q1 2022 | -1608% | -112% | -7.5% | 01 Jan 2022 | 31 Mar 2022 |
| Q4 2021 | -1796% | +340% | +16% | 01 Oct 2021 | 31 Dec 2021 |
| Q3 2021 | -1387% | 01 Jul 2021 | 30 Sep 2021 | ||
| Q2 2021 | -1353% | 01 Apr 2021 | 30 Jun 2021 | ||
| Q1 2021 | -1497% | 01 Jan 2021 | 31 Mar 2021 | ||
| Q4 2020 | -2136% | 01 Oct 2020 | 31 Dec 2020 |
RECURSION PHARMACEUTICALS, INC. Annual Operating Margin (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2025 | -868% | -54% | -6.6% | 01 Jan 2025 | 31 Dec 2025 |
| 2024 | -814% | -29% | -3.7% | 01 Jan 2024 | 31 Dec 2024 |
| 2023 | -785% | -169% | -27% | 01 Jan 2023 | 31 Dec 2023 |
| 2022 | -617% | +1179% | +66% | 01 Jan 2022 | 31 Dec 2022 |
| 2021 | -1796% | +340% | +16% | 01 Jan 2021 | 31 Dec 2021 |
| 2020 | -2136% | +557% | +21% | 01 Jan 2020 | 31 Dec 2020 |
| 2019 | -2693% | 01 Jan 2019 | 31 Dec 2019 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.